+44 1223 790975
+44 1223 790975
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 4334 citations as per Google Scholar report
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
| Journal total citations count | 4334 |
| Journal impact factor | 2.04 |
| Journal 5 years impact factor | 3.14 |
| Journal cite score | 10.01 |
| Journal h-index | 25 |
| Journal h-index since 2019 | 22 |
 |
Atropa belladonna Expresses a microRNA (aba-miRNA-9497) Highly Homologous to Homo sapiens miRNA-378 (hsa-miRNA-378); both miRNAs target the 3?-Untranslated Region (3?-UTR) of the mRNA Encoding the Neurologically Relevant, Zinc-Finger Transcription Fact |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
microRNA-based biomarkers in Alzheimer's disease (AD) |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Role of microRNA (miRNA) and viroids in lethal diseases of plants and animals. Potential contribution to human neurodegenerative disorders |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid ? Toxicity: Relevance to Alzheimer's Disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
microRNA-34a (miRNA-34a) mediated down-regulation of the post-synaptic cytoskeletal element SHANK3 in sporadic Alzheimer's disease (AD) |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Addressing Alzheimer's disease (AD) neuropathology using anti-microRNA (AM) strategies |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Microbiome-mediated upregulation of microRNA-146a in sporadic Alzheimer's disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
SARS-CoV-2 infectivity and neurological targets in the brain |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Bacteroidetes neurotoxins and inflammatory neurodegeneration |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
MicroRNAs in Alzheimer's disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer's disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
The role of ceramide and sphingosine-1-phosphate in Alzheimer's disease and other neurodegenerative disorders |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Prion disease in Indigenous Australians |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Therapeutic Efficacy of Plasmalogens for Alzheimerâs Disease, Mild Cognitive Impairment, and Parkinsonâs Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimerâs Disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
